{"pmid":32418306,"title":"Comment on Matricardi PM et al.: The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures.","text":["Comment on Matricardi PM et al.: The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures.","We read with great interest the review article by Matricardi and colleagues [1] depicting mechanisms of disease for COVID-19 and analyzing both viral and host factors influencing its course. We particularly agree with Authors on the pivotal role of innate immunity in the very early phase of disease, being crucial for the subsequent evolution. Most known weapons of innate immune system are represented by natural antibodies, non-specific antimicrobial proteins, interferons, cytokines and cellular elements (i.e. natural killer cells).[1] However, innate immunity could be influenced by other, still underrecognized, factors.","Pediatr Allergy Immunol","Mirijello, Antonio","D'Errico, Maria Maddalena","Lamarca, Antonella","Piscitelli, Pamela","De Cosmo, Salvatore","32418306"],"abstract":["We read with great interest the review article by Matricardi and colleagues [1] depicting mechanisms of disease for COVID-19 and analyzing both viral and host factors influencing its course. We particularly agree with Authors on the pivotal role of innate immunity in the very early phase of disease, being crucial for the subsequent evolution. Most known weapons of innate immune system are represented by natural antibodies, non-specific antimicrobial proteins, interferons, cytokines and cellular elements (i.e. natural killer cells).[1] However, innate immunity could be influenced by other, still underrecognized, factors."],"journal":"Pediatr Allergy Immunol","authors":["Mirijello, Antonio","D'Errico, Maria Maddalena","Lamarca, Antonella","Piscitelli, Pamela","De Cosmo, Salvatore"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32418306","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/pai.13277","weight":0,"_version_":1667058206860378112,"score":9.490897,"similar":[{"pmid":32359201,"title":"The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures.","text":["The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures.","The natural history of COVID-19 caused by SARS-CoV-2 is extremely variable, ranging from asymptomatic or mild infection, mainly in children, to multi-organ failure, eventually fatal, mainly in the eldest. We propose here the first model, explaining how the outcome of first, crucial 10-15 days after infection, hangs on the balance between the cumulative dose of viral exposure and the efficacy of the local innate immune response (natural IgA and IgM antibodies, Mannose Binding Lectin ). If SARS-CoV-2 runs the blockade of this innate immunity and spreads from the upper airways to the alveoli in the early phases of the infections, it can replicate with no local resistance, causing pneumonia and releasing high amounts of antigens. The delayed and strong adaptive immune response (high affinity IgM and IgG antibodies) that follows, causes severe inflammation and triggers mediator cascades (complement, coagulation, and cytokine storm) leading to complications often requiring intensive therapy and being, in some patients, fatal. Low-moderate physical activity can still be recommended. However, extreme physical activity and hyperventilation during the incubation days and early stages of COVID-19, facilitates early direct penetration of high numbers of virus particles in the lower airways and the alveoli, without impacting on the airway's mucosae covered by neutralizing antibodies. This allows the virus bypassing the efficient immune barrier of the upper airways mucosa in already infected, young and otherwise healthy athletes. In conclusion, whether the virus or the adaptative immune response reach the lungs first, is a crucial factor deciding the fate of the patient. This \"quantitative and time-sequence dependent\" model has several implications for prevention, diagnosis, and therapy of COVID-19 at all ages.","Pediatr Allergy Immunol","Matricardi, Paolo Maria","Dal Negro, Roberto Walter","Nisini, Roberto","32359201"],"abstract":["The natural history of COVID-19 caused by SARS-CoV-2 is extremely variable, ranging from asymptomatic or mild infection, mainly in children, to multi-organ failure, eventually fatal, mainly in the eldest. We propose here the first model, explaining how the outcome of first, crucial 10-15 days after infection, hangs on the balance between the cumulative dose of viral exposure and the efficacy of the local innate immune response (natural IgA and IgM antibodies, Mannose Binding Lectin ). If SARS-CoV-2 runs the blockade of this innate immunity and spreads from the upper airways to the alveoli in the early phases of the infections, it can replicate with no local resistance, causing pneumonia and releasing high amounts of antigens. The delayed and strong adaptive immune response (high affinity IgM and IgG antibodies) that follows, causes severe inflammation and triggers mediator cascades (complement, coagulation, and cytokine storm) leading to complications often requiring intensive therapy and being, in some patients, fatal. Low-moderate physical activity can still be recommended. However, extreme physical activity and hyperventilation during the incubation days and early stages of COVID-19, facilitates early direct penetration of high numbers of virus particles in the lower airways and the alveoli, without impacting on the airway's mucosae covered by neutralizing antibodies. This allows the virus bypassing the efficient immune barrier of the upper airways mucosa in already infected, young and otherwise healthy athletes. In conclusion, whether the virus or the adaptative immune response reach the lungs first, is a crucial factor deciding the fate of the patient. This \"quantitative and time-sequence dependent\" model has several implications for prevention, diagnosis, and therapy of COVID-19 at all ages."],"journal":"Pediatr Allergy Immunol","authors":["Matricardi, Paolo Maria","Dal Negro, Roberto Walter","Nisini, Roberto"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32359201","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/pai.13271","keywords":["antibodies","covid-19","sars-cov-2","glycans","immunoglobulin m","pneumonia","prediction","protection"],"e_drugs":["Mannose"],"topics":["Diagnosis","Prevention","Treatment","Mechanism"],"weight":1,"_version_":1666138495337365506,"score":306.7178},{"pmid":32501133,"title":"Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?","text":["Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?","The coronavirus disease (COVID-19) is resulting in millions of infected individuals with several hundred thousands dead throughout the world. Amidst all the havoc, one interesting observation in the present COVID-19 pandemic is the negligible symptoms in the young; particularly children below 10 years of age. We assume the extensive pediatric vaccination with MMR vaccines followed globally could have resulted in innate immune responses, e.g., induction of interferons (IFNs) and activated natural killer (NK) cells, thereby offering natural immunity against SARS-CoV-2 in the young population. Possible cross-protective innate immunity offered by MMR vaccination prompted us to suggest repurposing MMR vaccination for immuno-prophylaxis against COVID-19.","Hum Vaccin Immunother","Anbarasu, Anand","Ramaiah, Sudha","Livingstone, Paul","32501133"],"abstract":["The coronavirus disease (COVID-19) is resulting in millions of infected individuals with several hundred thousands dead throughout the world. Amidst all the havoc, one interesting observation in the present COVID-19 pandemic is the negligible symptoms in the young; particularly children below 10 years of age. We assume the extensive pediatric vaccination with MMR vaccines followed globally could have resulted in innate immune responses, e.g., induction of interferons (IFNs) and activated natural killer (NK) cells, thereby offering natural immunity against SARS-CoV-2 in the young population. Possible cross-protective innate immunity offered by MMR vaccination prompted us to suggest repurposing MMR vaccination for immuno-prophylaxis against COVID-19."],"journal":"Hum Vaccin Immunother","authors":["Anbarasu, Anand","Ramaiah, Sudha","Livingstone, Paul"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501133","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1080/21645515.2020.1773141","keywords":["covid-19","mmr vaccine","sars-cov-2","children","innate immunity","prophylaxis"],"topics":["Treatment"],"weight":1,"_version_":1668890966468067328,"score":224.09457},{"pmid":32344314,"pmcid":"PMC7194824","title":"Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents.","text":["Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents.","Following the outbreak of a novel coronavirus (SARS-CoV-2), studies suggest that the resultant disease (COVID-19) is more severe in individuals with a weakened immune system. Cytotoxic T-cells (CTLs) and Natural Killer (NK) cells are required to generate an effective immune response against viruses, functional exhaustion of which enables disease progression. Patients with severe COVID-19 present significantly lower lymphocyte, and higher neutrophil, counts in blood. Specifically, CD8(+) lymphocytes and NK cells were significantly reduced in cases of severe infection compared to patients with mild infection and healthy individuals. The NK group 2 member A (NKG2A) receptor transduces inhibitory signalling, suppressing NK cytokine secretion and cytotoxicity. Overexpression of NKG2A has been observed on CD8(+) and NK cells of COVID-19 infected patients compared to healthy controls, while NKG2A overexpression also functionally exhausts CD8(+) cells and NK cells, resulting in a severely compromised innate immune response. Blocking NKG2A on CD8(+) cells and NK cells in cancers modulated tumor growth, restoring CD8(+) T and NK cell function. A recently proposed mechanism via which SARS-CoV-2 overrides innate immune response of the host is by over-expressing NKG2A on CD(+) T and NK cells, culminating in functional exhaustion of the immune response against the viral pathogen. Monalizumab is an inhibiting antibody against NKG2A which can restore the function of CD8 + T and NK cells in cancers, successfully ceasing tumor progression with no significant side effects in Phase 2 clinical trials. We hypothesize that patients with severe COVID-19 have a severely compromised innate immune response and could be treated via the use of Monalizumab, interferon alpha, chloroquine, and other antiviral agents.","Med Hypotheses","Yaqinuddin, Ahmed","Kashir, Junaid","32344314"],"abstract":["Following the outbreak of a novel coronavirus (SARS-CoV-2), studies suggest that the resultant disease (COVID-19) is more severe in individuals with a weakened immune system. Cytotoxic T-cells (CTLs) and Natural Killer (NK) cells are required to generate an effective immune response against viruses, functional exhaustion of which enables disease progression. Patients with severe COVID-19 present significantly lower lymphocyte, and higher neutrophil, counts in blood. Specifically, CD8(+) lymphocytes and NK cells were significantly reduced in cases of severe infection compared to patients with mild infection and healthy individuals. The NK group 2 member A (NKG2A) receptor transduces inhibitory signalling, suppressing NK cytokine secretion and cytotoxicity. Overexpression of NKG2A has been observed on CD8(+) and NK cells of COVID-19 infected patients compared to healthy controls, while NKG2A overexpression also functionally exhausts CD8(+) cells and NK cells, resulting in a severely compromised innate immune response. Blocking NKG2A on CD8(+) cells and NK cells in cancers modulated tumor growth, restoring CD8(+) T and NK cell function. A recently proposed mechanism via which SARS-CoV-2 overrides innate immune response of the host is by over-expressing NKG2A on CD(+) T and NK cells, culminating in functional exhaustion of the immune response against the viral pathogen. Monalizumab is an inhibiting antibody against NKG2A which can restore the function of CD8 + T and NK cells in cancers, successfully ceasing tumor progression with no significant side effects in Phase 2 clinical trials. We hypothesize that patients with severe COVID-19 have a severely compromised innate immune response and could be treated via the use of Monalizumab, interferon alpha, chloroquine, and other antiviral agents."],"journal":"Med Hypotheses","authors":["Yaqinuddin, Ahmed","Kashir, Junaid"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344314","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.mehy.2020.109777","keywords":["covid-19","innate immunity","monalizumab","nkg2a","sars"],"locations":["Monalizumab"],"e_drugs":["Chloroquine"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495873187840,"score":207.53902},{"pmid":32403318,"title":"Porcine Epidemic Diarrhea Virus and the Host Innate Immune Response.","text":["Porcine Epidemic Diarrhea Virus and the Host Innate Immune Response.","Porcine epidemic diarrhea virus (PEDV), a swine enteropathogenic coronavirus (CoV), is the causative agent of porcine epidemic diarrhea (PED). PED causes lethal watery diarrhea in piglets, which has led to substantial economic losses in many countries and is a great threat to the global swine industry. Interferons (IFNs) are major cytokines involved in host innate immune defense, which induce the expression of a broad range of antiviral effectors that help host to control and antagonize viral infections. PEDV infection does not elicit a robust IFN response, and some of the mechanisms used by the virus to counteract the host innate immune response have been unraveled. PEDV evades the host innate immune response by two main strategies including: (1) encoding IFN antagonists to disrupt innate immune pathway, and (2) hiding its viral RNA to avoid the exposure of viral RNA to immune sensors. This review highlights the immune evasion mechanisms employed by PEDV, which provides insights for the better understanding of PEDV-host interactions and developing effective vaccines and antivirals against CoVs.","Pathogens","Li, Shasha","Yang, Jinping","Zhu, Zixiang","Zheng, Haixue","32403318"],"abstract":["Porcine epidemic diarrhea virus (PEDV), a swine enteropathogenic coronavirus (CoV), is the causative agent of porcine epidemic diarrhea (PED). PED causes lethal watery diarrhea in piglets, which has led to substantial economic losses in many countries and is a great threat to the global swine industry. Interferons (IFNs) are major cytokines involved in host innate immune defense, which induce the expression of a broad range of antiviral effectors that help host to control and antagonize viral infections. PEDV infection does not elicit a robust IFN response, and some of the mechanisms used by the virus to counteract the host innate immune response have been unraveled. PEDV evades the host innate immune response by two main strategies including: (1) encoding IFN antagonists to disrupt innate immune pathway, and (2) hiding its viral RNA to avoid the exposure of viral RNA to immune sensors. This review highlights the immune evasion mechanisms employed by PEDV, which provides insights for the better understanding of PEDV-host interactions and developing effective vaccines and antivirals against CoVs."],"journal":"Pathogens","authors":["Li, Shasha","Yang, Jinping","Zhu, Zixiang","Zheng, Haixue"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32403318","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/pathogens9050367","keywords":["coronavirus","immune evasion","innate immunity","porcine epidemic diarrhea virus","type i ifn"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666802845642391552,"score":183.20044},{"pmid":32432519,"title":"Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?","text":["Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?","Rotating and permanent night shiftwork schedules typically result in acute and sometimes chronic sleep deprivation plus acute and sometimes chronic disruption of the circadian time structure. Immune system processes and functionalities are organized as circadian rhythms, and they are also strongly influenced by sleep status. Sleep is a vital behavioral state of living beings and a modulator of immune function and responsiveness. Shiftworkers show increased risk for developing viral infections due to possible compromise of both innate and acquired immunity responses. Short sleep and sleep loss, common consequences of shiftwork, are associated with altered integrity of the immune system. We discuss the possible excess risk for COVID-19 infection in the context of the common conditions among shiftworkers, including nurses, doctors, and first responders, among others of high exposure to the contagion, of sleep imbalance and circadian disruption.Abbreviations: ACE2: Angiotensin-converting enzyme 2; APC: Antigen-presenting cells; CCL: Chemokine (C-C motif) ligand; CD(+): Adhesion molecule expression; COVID-19: 2019 coronavirus disease; DCs: Dendritic cells; GH: Growth hormone; HPA: Hypothalamic-pituitary-adrenal; HSF: Heat shock factor; HSP70: Heat shock protein 70; HSP90: Heat shock protein 90; IL: Interleukin; INFgamma: Interferon-gamma; LT/LB: T/B lymphocytes; MHC: Major histocompatibility complex; NK: Natural killer; RAAS: renin-angiotensin-aldosterone system; SARS: Severe acute respiratory syndrome; SCN: Suprachiasmatic nucleus;SD: Sleep deprivation; SNS: Sympathetic nervous system; Th1/Th2: T helper lymphocytes 1/2; TLR2/TLR4: Toll-like receptor 2/4; TNF-alpha: Tumor necrosis factor alpha; VEGF: Vascular endothelial growth factor.","Chronobiol Int","Silva, Flavia Rodrigues da","Guerreiro, Renato de Carvalho","Andrade, Henrique de Araujo","Stieler, Eduardo","Silva, Andressa","de Mello, Marco Tulio","32432519"],"abstract":["Rotating and permanent night shiftwork schedules typically result in acute and sometimes chronic sleep deprivation plus acute and sometimes chronic disruption of the circadian time structure. Immune system processes and functionalities are organized as circadian rhythms, and they are also strongly influenced by sleep status. Sleep is a vital behavioral state of living beings and a modulator of immune function and responsiveness. Shiftworkers show increased risk for developing viral infections due to possible compromise of both innate and acquired immunity responses. Short sleep and sleep loss, common consequences of shiftwork, are associated with altered integrity of the immune system. We discuss the possible excess risk for COVID-19 infection in the context of the common conditions among shiftworkers, including nurses, doctors, and first responders, among others of high exposure to the contagion, of sleep imbalance and circadian disruption.Abbreviations: ACE2: Angiotensin-converting enzyme 2; APC: Antigen-presenting cells; CCL: Chemokine (C-C motif) ligand; CD(+): Adhesion molecule expression; COVID-19: 2019 coronavirus disease; DCs: Dendritic cells; GH: Growth hormone; HPA: Hypothalamic-pituitary-adrenal; HSF: Heat shock factor; HSP70: Heat shock protein 70; HSP90: Heat shock protein 90; IL: Interleukin; INFgamma: Interferon-gamma; LT/LB: T/B lymphocytes; MHC: Major histocompatibility complex; NK: Natural killer; RAAS: renin-angiotensin-aldosterone system; SARS: Severe acute respiratory syndrome; SCN: Suprachiasmatic nucleus;SD: Sleep deprivation; SNS: Sympathetic nervous system; Th1/Th2: T helper lymphocytes 1/2; TLR2/TLR4: Toll-like receptor 2/4; TNF-alpha: Tumor necrosis factor alpha; VEGF: Vascular endothelial growth factor."],"journal":"Chronobiol Int","authors":["Silva, Flavia Rodrigues da","Guerreiro, Renato de Carvalho","Andrade, Henrique de Araujo","Stieler, Eduardo","Silva, Andressa","de Mello, Marco Tulio"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32432519","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/07420528.2020.1756841","keywords":["covid-19","circadian disruption","immune system","shiftwork","sleep deprivation"],"locations":["circadian","circadian"],"topics":["Prevention"],"weight":1,"_version_":1667342288420864000,"score":175.49174}]}